nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR1B—alcohol dependence	0.142	0.323	CbGaD
Atomoxetine—SLC6A3—alcohol dependence	0.129	0.292	CbGaD
Atomoxetine—SLC6A4—alcohol dependence	0.0962	0.218	CbGaD
Atomoxetine—SLC6A3—Citalopram—alcohol dependence	0.075	0.239	CbGbCtD
Atomoxetine—HTR2A—alcohol dependence	0.0739	0.168	CbGaD
Atomoxetine—SLC6A4—Citalopram—alcohol dependence	0.0656	0.209	CbGbCtD
Atomoxetine—HTR2C—Citalopram—alcohol dependence	0.0549	0.175	CbGbCtD
Atomoxetine—SLC6A2—Citalopram—alcohol dependence	0.0549	0.175	CbGbCtD
Atomoxetine—CYP2C19—Citalopram—alcohol dependence	0.0216	0.069	CbGbCtD
Atomoxetine—CYP2D6—Citalopram—alcohol dependence	0.0165	0.0525	CbGbCtD
Atomoxetine—CYP3A4—Disulfiram—alcohol dependence	0.0147	0.0468	CbGbCtD
Atomoxetine—CYP3A4—Citalopram—alcohol dependence	0.0105	0.0334	CbGbCtD
Atomoxetine—SLC6A2—locus ceruleus—alcohol dependence	0.00295	0.0685	CbGeAlD
Atomoxetine—NPY1R—nerve—alcohol dependence	0.0026	0.0603	CbGeAlD
Atomoxetine—HTR2A—locus ceruleus—alcohol dependence	0.00177	0.0411	CbGeAlD
Atomoxetine—SLC6A2—autonomic nervous system—alcohol dependence	0.00157	0.0364	CbGeAlD
Atomoxetine—HTR2A—cerebellar cortex—alcohol dependence	0.00145	0.0335	CbGeAlD
Atomoxetine—SLC6A3—nerve—alcohol dependence	0.00109	0.0254	CbGeAlD
Atomoxetine—NPY1R—forebrain—alcohol dependence	0.00108	0.025	CbGeAlD
Atomoxetine—HTR2A—pons—alcohol dependence	0.00102	0.0237	CbGeAlD
Atomoxetine—NPY1R—adrenal cortex—alcohol dependence	0.000998	0.0231	CbGeAlD
Atomoxetine—HTR2A—autonomic nervous system—alcohol dependence	0.000943	0.0219	CbGeAlD
Atomoxetine—NPY1R—pancreas—alcohol dependence	0.000885	0.0205	CbGeAlD
Atomoxetine—SLC6A2—nerve—alcohol dependence	0.000882	0.0205	CbGeAlD
Atomoxetine—NPY1R—gonad—alcohol dependence	0.000826	0.0192	CbGeAlD
Atomoxetine—HTR6—forebrain—alcohol dependence	0.000758	0.0176	CbGeAlD
Atomoxetine—NPY1R—blood—alcohol dependence	0.00072	0.0167	CbGeAlD
Atomoxetine—NPY1R—endocrine gland—alcohol dependence	0.000624	0.0145	CbGeAlD
Atomoxetine—NPY1R—testis—alcohol dependence	0.000596	0.0138	CbGeAlD
Atomoxetine—NPY1R—nervous system—alcohol dependence	0.000584	0.0136	CbGeAlD
Atomoxetine—NPY1R—liver—alcohol dependence	0.000563	0.0131	CbGeAlD
Atomoxetine—NPY1R—central nervous system—alcohol dependence	0.000563	0.0131	CbGeAlD
Atomoxetine—HTR2A—nerve—alcohol dependence	0.00053	0.0123	CbGeAlD
Atomoxetine—HTR1B—brainstem—alcohol dependence	0.000473	0.011	CbGeAlD
Atomoxetine—SLC6A3—brainstem—alcohol dependence	0.000469	0.0109	CbGeAlD
Atomoxetine—HTR1D—brainstem—alcohol dependence	0.000458	0.0106	CbGeAlD
Atomoxetine—HTR1B—forebrain—alcohol dependence	0.000457	0.0106	CbGeAlD
Atomoxetine—HTR2C—brainstem—alcohol dependence	0.000454	0.0105	CbGeAlD
Atomoxetine—SLC6A3—forebrain—alcohol dependence	0.000453	0.0105	CbGeAlD
Atomoxetine—NPY1R—brain—alcohol dependence	0.000447	0.0104	CbGeAlD
Atomoxetine—HTR1D—forebrain—alcohol dependence	0.000442	0.0103	CbGeAlD
Atomoxetine—HTR2C—forebrain—alcohol dependence	0.000438	0.0102	CbGeAlD
Atomoxetine—SLC6A4—brainstem—alcohol dependence	0.00043	0.00998	CbGeAlD
Atomoxetine—SLC6A4—forebrain—alcohol dependence	0.000415	0.00963	CbGeAlD
Atomoxetine—HTR6—nervous system—alcohol dependence	0.000411	0.00954	CbGeAlD
Atomoxetine—HTR6—central nervous system—alcohol dependence	0.000396	0.00919	CbGeAlD
Atomoxetine—HTR1B—cardiovascular system—alcohol dependence	0.000386	0.00896	CbGeAlD
Atomoxetine—SLC6A2—brainstem—alcohol dependence	0.000379	0.00878	CbGeAlD
Atomoxetine—HTR1D—cardiovascular system—alcohol dependence	0.000374	0.00867	CbGeAlD
Atomoxetine—SLC6A2—forebrain—alcohol dependence	0.000365	0.00848	CbGeAlD
Atomoxetine—Rhinorrhoea—Citalopram—alcohol dependence	0.000339	0.0028	CcSEcCtD
Atomoxetine—Rigors—Citalopram—alcohol dependence	0.000336	0.00278	CcSEcCtD
Atomoxetine—Hot flush—Naltrexone—alcohol dependence	0.000336	0.00278	CcSEcCtD
Atomoxetine—Menopausal symptoms—Naltrexone—alcohol dependence	0.000333	0.00275	CcSEcCtD
Atomoxetine—Thirst—Naltrexone—alcohol dependence	0.00033	0.00273	CcSEcCtD
Atomoxetine—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00033	0.00272	CcSEcCtD
Atomoxetine—Psychotic disorder—Acamprosate—alcohol dependence	0.000324	0.00268	CcSEcCtD
Atomoxetine—Lethargy—Naltrexone—alcohol dependence	0.000321	0.00265	CcSEcCtD
Atomoxetine—Delirium—Citalopram—alcohol dependence	0.000319	0.00264	CcSEcCtD
Atomoxetine—HTR6—brain—alcohol dependence	0.000314	0.00729	CbGeAlD
Atomoxetine—Aggression—Citalopram—alcohol dependence	0.000312	0.00258	CcSEcCtD
Atomoxetine—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.000312	0.00258	CcSEcCtD
Atomoxetine—Psychotic disorder—Naltrexone—alcohol dependence	0.000307	0.00254	CcSEcCtD
Atomoxetine—Bone disorder—Citalopram—alcohol dependence	0.000304	0.00251	CcSEcCtD
Atomoxetine—Dysmenorrhoea—Citalopram—alcohol dependence	0.000302	0.00249	CcSEcCtD
Atomoxetine—HTR1B—midbrain—alcohol dependence	0.000302	0.007	CbGeAlD
Atomoxetine—Breast disorder—Acamprosate—alcohol dependence	0.0003	0.00248	CcSEcCtD
Atomoxetine—Irritability—Naltrexone—alcohol dependence	0.0003	0.00248	CcSEcCtD
Atomoxetine—SLC6A3—midbrain—alcohol dependence	0.000299	0.00694	CbGeAlD
Atomoxetine—Paraesthesia—Disulfiram—alcohol dependence	0.000298	0.00246	CcSEcCtD
Atomoxetine—Drug interaction—Citalopram—alcohol dependence	0.000296	0.00244	CcSEcCtD
Atomoxetine—Somnolence—Disulfiram—alcohol dependence	0.000295	0.00244	CcSEcCtD
Atomoxetine—HTR1D—midbrain—alcohol dependence	0.000292	0.00677	CbGeAlD
Atomoxetine—SLC6A4—digestive system—alcohol dependence	0.000291	0.00676	CbGeAlD
Atomoxetine—HTR2C—midbrain—alcohol dependence	0.000289	0.00671	CbGeAlD
Atomoxetine—Influenza—Acamprosate—alcohol dependence	0.000287	0.00237	CcSEcCtD
Atomoxetine—Abdominal pain upper—Naltrexone—alcohol dependence	0.000287	0.00237	CcSEcCtD
Atomoxetine—Fatigue—Disulfiram—alcohol dependence	0.000286	0.00236	CcSEcCtD
Atomoxetine—Pain—Disulfiram—alcohol dependence	0.000283	0.00234	CcSEcCtD
Atomoxetine—Nasopharyngitis—Naltrexone—alcohol dependence	0.000281	0.00232	CcSEcCtD
Atomoxetine—SLC6A2—gonad—alcohol dependence	0.00028	0.00651	CbGeAlD
Atomoxetine—SLC6A4—blood—alcohol dependence	0.000278	0.00644	CbGeAlD
Atomoxetine—Blood pressure increased—Citalopram—alcohol dependence	0.000274	0.00227	CcSEcCtD
Atomoxetine—SLC6A4—midbrain—alcohol dependence	0.000274	0.00636	CbGeAlD
Atomoxetine—Influenza—Naltrexone—alcohol dependence	0.000272	0.00225	CcSEcCtD
Atomoxetine—Abnormal dreams—Citalopram—alcohol dependence	0.000271	0.00224	CcSEcCtD
Atomoxetine—Pollakiuria—Acamprosate—alcohol dependence	0.000265	0.00219	CcSEcCtD
Atomoxetine—HTR1B—endocrine gland—alcohol dependence	0.000265	0.00615	CbGeAlD
Atomoxetine—Sweating increased—Naltrexone—alcohol dependence	0.000265	0.00219	CcSEcCtD
Atomoxetine—Erectile dysfunction—Acamprosate—alcohol dependence	0.000264	0.00219	CcSEcCtD
Atomoxetine—Abdominal discomfort—Naltrexone—alcohol dependence	0.00026	0.00215	CcSEcCtD
Atomoxetine—Weight decreased—Acamprosate—alcohol dependence	0.00026	0.00215	CcSEcCtD
Atomoxetine—Depression—Acamprosate—alcohol dependence	0.000255	0.00211	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000252	0.00209	CcSEcCtD
Atomoxetine—Coma—Citalopram—alcohol dependence	0.000251	0.00207	CcSEcCtD
Atomoxetine—SLC6A3—testis—alcohol dependence	0.000251	0.00581	CbGeAlD
Atomoxetine—HTR1B—nervous system—alcohol dependence	0.000248	0.00575	CbGeAlD
Atomoxetine—SLC6A3—nervous system—alcohol dependence	0.000246	0.0057	CbGeAlD
Atomoxetine—Weight decreased—Naltrexone—alcohol dependence	0.000246	0.00203	CcSEcCtD
Atomoxetine—Infestation NOS—Naltrexone—alcohol dependence	0.000242	0.002	CcSEcCtD
Atomoxetine—Infestation—Naltrexone—alcohol dependence	0.000242	0.002	CcSEcCtD
Atomoxetine—Depression—Naltrexone—alcohol dependence	0.000241	0.002	CcSEcCtD
Atomoxetine—CYP2C19—digestive system—alcohol dependence	0.000241	0.0056	CbGeAlD
Atomoxetine—SLC6A4—endocrine gland—alcohol dependence	0.000241	0.00559	CbGeAlD
Atomoxetine—HTR1D—nervous system—alcohol dependence	0.00024	0.00557	CbGeAlD
Atomoxetine—HTR1B—central nervous system—alcohol dependence	0.000239	0.00554	CbGeAlD
Atomoxetine—Asthenia—Disulfiram—alcohol dependence	0.000238	0.00197	CcSEcCtD
Atomoxetine—HTR2C—nervous system—alcohol dependence	0.000238	0.00551	CbGeAlD
Atomoxetine—SLC6A3—central nervous system—alcohol dependence	0.000237	0.00549	CbGeAlD
Atomoxetine—Conjunctivitis—Naltrexone—alcohol dependence	0.000235	0.00195	CcSEcCtD
Atomoxetine—SLC6A3—cerebellum—alcohol dependence	0.000231	0.00537	CbGeAlD
Atomoxetine—HTR1D—central nervous system—alcohol dependence	0.000231	0.00536	CbGeAlD
Atomoxetine—Sleep disorder—Citalopram—alcohol dependence	0.00023	0.0019	CcSEcCtD
Atomoxetine—CYP2C19—blood—alcohol dependence	0.00023	0.00534	CbGeAlD
Atomoxetine—HTR2C—central nervous system—alcohol dependence	0.000229	0.00531	CbGeAlD
Atomoxetine—Hypoaesthesia—Acamprosate—alcohol dependence	0.000229	0.00189	CcSEcCtD
Atomoxetine—Hallucination—Acamprosate—alcohol dependence	0.000229	0.00189	CcSEcCtD
Atomoxetine—HTR2A—brainstem—alcohol dependence	0.000228	0.00528	CbGeAlD
Atomoxetine—Sinusitis—Naltrexone—alcohol dependence	0.000227	0.00188	CcSEcCtD
Atomoxetine—SLC6A4—nervous system—alcohol dependence	0.000225	0.00523	CbGeAlD
Atomoxetine—Disorientation—Citalopram—alcohol dependence	0.000223	0.00184	CcSEcCtD
Atomoxetine—Hepatic failure—Citalopram—alcohol dependence	0.000222	0.00183	CcSEcCtD
Atomoxetine—HTR2A—forebrain—alcohol dependence	0.00022	0.0051	CbGeAlD
Atomoxetine—Dizziness—Disulfiram—alcohol dependence	0.000219	0.00181	CcSEcCtD
Atomoxetine—Nasal congestion—Citalopram—alcohol dependence	0.000219	0.00181	CcSEcCtD
Atomoxetine—SLC6A4—central nervous system—alcohol dependence	0.000217	0.00503	CbGeAlD
Atomoxetine—Hallucination—Naltrexone—alcohol dependence	0.000216	0.00179	CcSEcCtD
Atomoxetine—Libido decreased—Citalopram—alcohol dependence	0.000215	0.00178	CcSEcCtD
Atomoxetine—Hot flush—Citalopram—alcohol dependence	0.000213	0.00176	CcSEcCtD
Atomoxetine—SLC6A2—endocrine gland—alcohol dependence	0.000212	0.00492	CbGeAlD
Atomoxetine—Menopausal symptoms—Citalopram—alcohol dependence	0.000211	0.00174	CcSEcCtD
Atomoxetine—Thirst—Citalopram—alcohol dependence	0.000209	0.00173	CcSEcCtD
Atomoxetine—Rash—Disulfiram—alcohol dependence	0.000209	0.00173	CcSEcCtD
Atomoxetine—Headache—Disulfiram—alcohol dependence	0.000208	0.00172	CcSEcCtD
Atomoxetine—CYP2D6—brainstem—alcohol dependence	0.000207	0.00481	CbGeAlD
Atomoxetine—Chills—Acamprosate—alcohol dependence	0.000206	0.0017	CcSEcCtD
Atomoxetine—Lethargy—Citalopram—alcohol dependence	0.000203	0.00168	CcSEcCtD
Atomoxetine—SLC6A2—testis—alcohol dependence	0.000202	0.00469	CbGeAlD
Atomoxetine—Cardiac disorder—Naltrexone—alcohol dependence	0.000202	0.00167	CcSEcCtD
Atomoxetine—Mental disorder—Acamprosate—alcohol dependence	0.000201	0.00166	CcSEcCtD
Atomoxetine—CYP2D6—forebrain—alcohol dependence	0.0002	0.00464	CbGeAlD
Atomoxetine—Malnutrition—Acamprosate—alcohol dependence	0.0002	0.00165	CcSEcCtD
Atomoxetine—CYP2C19—endocrine gland—alcohol dependence	0.0002	0.00463	CbGeAlD
Atomoxetine—SLC6A2—nervous system—alcohol dependence	0.000198	0.0046	CbGeAlD
Atomoxetine—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000198	0.00163	CcSEcCtD
Atomoxetine—Angiopathy—Naltrexone—alcohol dependence	0.000197	0.00163	CcSEcCtD
Atomoxetine—Flatulence—Acamprosate—alcohol dependence	0.000197	0.00163	CcSEcCtD
Atomoxetine—Tension—Acamprosate—alcohol dependence	0.000196	0.00162	CcSEcCtD
Atomoxetine—Affect lability—Citalopram—alcohol dependence	0.000196	0.00162	CcSEcCtD
Atomoxetine—Mediastinal disorder—Naltrexone—alcohol dependence	0.000196	0.00162	CcSEcCtD
Atomoxetine—Dysgeusia—Acamprosate—alcohol dependence	0.000196	0.00162	CcSEcCtD
Atomoxetine—Chills—Naltrexone—alcohol dependence	0.000195	0.00161	CcSEcCtD
Atomoxetine—Psychotic disorder—Citalopram—alcohol dependence	0.000194	0.00161	CcSEcCtD
Atomoxetine—Nervousness—Acamprosate—alcohol dependence	0.000194	0.00161	CcSEcCtD
Atomoxetine—Back pain—Acamprosate—alcohol dependence	0.000193	0.0016	CcSEcCtD
Atomoxetine—Muscle spasms—Acamprosate—alcohol dependence	0.000192	0.00159	CcSEcCtD
Atomoxetine—SLC6A2—central nervous system—alcohol dependence	0.000191	0.00443	CbGeAlD
Atomoxetine—Mental disorder—Naltrexone—alcohol dependence	0.00019	0.00157	CcSEcCtD
Atomoxetine—Irritability—Citalopram—alcohol dependence	0.00019	0.00157	CcSEcCtD
Atomoxetine—HTR1B—brain—alcohol dependence	0.00019	0.0044	CbGeAlD
Atomoxetine—Urinary retention—Citalopram—alcohol dependence	0.000189	0.00157	CcSEcCtD
Atomoxetine—Malnutrition—Naltrexone—alcohol dependence	0.000189	0.00156	CcSEcCtD
Atomoxetine—Mood swings—Citalopram—alcohol dependence	0.000189	0.00156	CcSEcCtD
Atomoxetine—SLC6A3—brain—alcohol dependence	0.000188	0.00436	CbGeAlD
Atomoxetine—Tremor—Acamprosate—alcohol dependence	0.000187	0.00155	CcSEcCtD
Atomoxetine—Flatulence—Naltrexone—alcohol dependence	0.000187	0.00154	CcSEcCtD
Atomoxetine—HTR2A—cardiovascular system—alcohol dependence	0.000186	0.00431	CbGeAlD
Atomoxetine—Tension—Naltrexone—alcohol dependence	0.000186	0.00154	CcSEcCtD
Atomoxetine—Dysgeusia—Naltrexone—alcohol dependence	0.000185	0.00153	CcSEcCtD
Atomoxetine—Agitation—Acamprosate—alcohol dependence	0.000184	0.00152	CcSEcCtD
Atomoxetine—Nervousness—Naltrexone—alcohol dependence	0.000184	0.00152	CcSEcCtD
Atomoxetine—HTR1D—brain—alcohol dependence	0.000183	0.00426	CbGeAlD
Atomoxetine—Back pain—Naltrexone—alcohol dependence	0.000183	0.00151	CcSEcCtD
Atomoxetine—Muscle spasms—Naltrexone—alcohol dependence	0.000182	0.0015	CcSEcCtD
Atomoxetine—Abdominal pain upper—Citalopram—alcohol dependence	0.000182	0.0015	CcSEcCtD
Atomoxetine—HTR2C—brain—alcohol dependence	0.000182	0.00421	CbGeAlD
Atomoxetine—Breast disorder—Citalopram—alcohol dependence	0.00018	0.00149	CcSEcCtD
Atomoxetine—CYP2C19—liver—alcohol dependence	0.00018	0.00417	CbGeAlD
Atomoxetine—Vertigo—Acamprosate—alcohol dependence	0.00018	0.00149	CcSEcCtD
Atomoxetine—Syncope—Acamprosate—alcohol dependence	0.000179	0.00148	CcSEcCtD
Atomoxetine—Vision blurred—Naltrexone—alcohol dependence	0.000178	0.00147	CcSEcCtD
Atomoxetine—Nasopharyngitis—Citalopram—alcohol dependence	0.000178	0.00147	CcSEcCtD
Atomoxetine—Tremor—Naltrexone—alcohol dependence	0.000177	0.00147	CcSEcCtD
Atomoxetine—Palpitations—Acamprosate—alcohol dependence	0.000177	0.00146	CcSEcCtD
Atomoxetine—Loss of consciousness—Acamprosate—alcohol dependence	0.000176	0.00145	CcSEcCtD
Atomoxetine—Cough—Acamprosate—alcohol dependence	0.000175	0.00144	CcSEcCtD
Atomoxetine—Agitation—Naltrexone—alcohol dependence	0.000174	0.00144	CcSEcCtD
Atomoxetine—Convulsion—Acamprosate—alcohol dependence	0.000173	0.00143	CcSEcCtD
Atomoxetine—SLC6A4—brain—alcohol dependence	0.000172	0.004	CbGeAlD
Atomoxetine—Influenza—Citalopram—alcohol dependence	0.000172	0.00142	CcSEcCtD
Atomoxetine—Diphenylpyraline—SLC6A3—alcohol dependence	0.000171	0.0456	CrCbGaD
Atomoxetine—Myalgia—Acamprosate—alcohol dependence	0.00017	0.00141	CcSEcCtD
Atomoxetine—Arthralgia—Acamprosate—alcohol dependence	0.00017	0.00141	CcSEcCtD
Atomoxetine—Chest pain—Acamprosate—alcohol dependence	0.00017	0.00141	CcSEcCtD
Atomoxetine—Syncope—Naltrexone—alcohol dependence	0.00017	0.0014	CcSEcCtD
Atomoxetine—Anxiety—Acamprosate—alcohol dependence	0.00017	0.0014	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000169	0.0014	CcSEcCtD
Atomoxetine—HTR2A—gonad—alcohol dependence	0.000169	0.00391	CbGeAlD
Atomoxetine—Sweating increased—Citalopram—alcohol dependence	0.000168	0.00139	CcSEcCtD
Atomoxetine—Palpitations—Naltrexone—alcohol dependence	0.000167	0.00138	CcSEcCtD
Atomoxetine—Dry mouth—Acamprosate—alcohol dependence	0.000167	0.00138	CcSEcCtD
Atomoxetine—Loss of consciousness—Naltrexone—alcohol dependence	0.000166	0.00138	CcSEcCtD
Atomoxetine—Cough—Naltrexone—alcohol dependence	0.000165	0.00137	CcSEcCtD
Atomoxetine—Abdominal discomfort—Citalopram—alcohol dependence	0.000165	0.00136	CcSEcCtD
Atomoxetine—Methadone—OPRK1—alcohol dependence	0.000164	0.0437	CrCbGaD
Atomoxetine—Convulsion—Naltrexone—alcohol dependence	0.000164	0.00136	CcSEcCtD
Atomoxetine—Infection—Acamprosate—alcohol dependence	0.000162	0.00134	CcSEcCtD
Atomoxetine—Myalgia—Naltrexone—alcohol dependence	0.000161	0.00133	CcSEcCtD
Atomoxetine—Chest pain—Naltrexone—alcohol dependence	0.000161	0.00133	CcSEcCtD
Atomoxetine—Arthralgia—Naltrexone—alcohol dependence	0.000161	0.00133	CcSEcCtD
Atomoxetine—Dysuria—Citalopram—alcohol dependence	0.000161	0.00133	CcSEcCtD
Atomoxetine—Shock—Acamprosate—alcohol dependence	0.000161	0.00133	CcSEcCtD
Atomoxetine—Anxiety—Naltrexone—alcohol dependence	0.000161	0.00133	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00016	0.00132	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00016	0.00132	CcSEcCtD
Atomoxetine—Duloxetine—SLC6A3—alcohol dependence	0.00016	0.0425	CrCbGaD
Atomoxetine—Tachycardia—Acamprosate—alcohol dependence	0.000159	0.00132	CcSEcCtD
Atomoxetine—Pollakiuria—Citalopram—alcohol dependence	0.000159	0.00131	CcSEcCtD
Atomoxetine—Skin disorder—Acamprosate—alcohol dependence	0.000159	0.00131	CcSEcCtD
Atomoxetine—Erectile dysfunction—Citalopram—alcohol dependence	0.000159	0.00131	CcSEcCtD
Atomoxetine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000158	0.0013	CcSEcCtD
Atomoxetine—Dry mouth—Naltrexone—alcohol dependence	0.000158	0.0013	CcSEcCtD
Atomoxetine—Tolterodine—CHRM2—alcohol dependence	0.000157	0.0417	CrCbGaD
Atomoxetine—Weight decreased—Citalopram—alcohol dependence	0.000156	0.00129	CcSEcCtD
Atomoxetine—Anorexia—Acamprosate—alcohol dependence	0.000156	0.00129	CcSEcCtD
Atomoxetine—Reboxetine—SLC6A4—alcohol dependence	0.000155	0.0413	CrCbGaD
Atomoxetine—HTR2A—digestive system—alcohol dependence	0.000154	0.00358	CbGeAlD
Atomoxetine—Infection—Naltrexone—alcohol dependence	0.000153	0.00127	CcSEcCtD
Atomoxetine—Infestation—Citalopram—alcohol dependence	0.000153	0.00127	CcSEcCtD
Atomoxetine—Infestation NOS—Citalopram—alcohol dependence	0.000153	0.00127	CcSEcCtD
Atomoxetine—Depression—Citalopram—alcohol dependence	0.000153	0.00127	CcSEcCtD
Atomoxetine—Shock—Naltrexone—alcohol dependence	0.000152	0.00126	CcSEcCtD
Atomoxetine—SLC6A2—brain—alcohol dependence	0.000152	0.00352	CbGeAlD
Atomoxetine—Nervous system disorder—Naltrexone—alcohol dependence	0.000151	0.00125	CcSEcCtD
Atomoxetine—Tachycardia—Naltrexone—alcohol dependence	0.000151	0.00125	CcSEcCtD
Atomoxetine—Benzatropine—CHRM2—alcohol dependence	0.000151	0.0401	CrCbGaD
Atomoxetine—Skin disorder—Naltrexone—alcohol dependence	0.00015	0.00124	CcSEcCtD
Atomoxetine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000149	0.00123	CcSEcCtD
Atomoxetine—Conjunctivitis—Citalopram—alcohol dependence	0.000149	0.00123	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000149	0.00123	CcSEcCtD
Atomoxetine—Insomnia—Acamprosate—alcohol dependence	0.000148	0.00122	CcSEcCtD
Atomoxetine—Anorexia—Naltrexone—alcohol dependence	0.000147	0.00122	CcSEcCtD
Atomoxetine—HTR2A—blood—alcohol dependence	0.000147	0.00341	CbGeAlD
Atomoxetine—Paraesthesia—Acamprosate—alcohol dependence	0.000147	0.00121	CcSEcCtD
Atomoxetine—Somnolence—Acamprosate—alcohol dependence	0.000145	0.0012	CcSEcCtD
Atomoxetine—HTR2A—midbrain—alcohol dependence	0.000145	0.00336	CbGeAlD
Atomoxetine—Sinusitis—Citalopram—alcohol dependence	0.000144	0.00119	CcSEcCtD
Atomoxetine—Dyspepsia—Acamprosate—alcohol dependence	0.000144	0.00119	CcSEcCtD
Atomoxetine—CYP3A4—digestive system—alcohol dependence	0.000143	0.00331	CbGeAlD
Atomoxetine—Protriptyline—SLC6A4—alcohol dependence	0.000142	0.0379	CrCbGaD
Atomoxetine—Decreased appetite—Acamprosate—alcohol dependence	0.000142	0.00117	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000141	0.00117	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000141	0.00116	CcSEcCtD
Atomoxetine—CYP2D6—digestive system—alcohol dependence	0.00014	0.00326	CbGeAlD
Atomoxetine—Insomnia—Naltrexone—alcohol dependence	0.00014	0.00116	CcSEcCtD
Atomoxetine—Pain—Acamprosate—alcohol dependence	0.00014	0.00115	CcSEcCtD
Atomoxetine—Constipation—Acamprosate—alcohol dependence	0.00014	0.00115	CcSEcCtD
Atomoxetine—Maprotiline—CHRM2—alcohol dependence	0.00014	0.0372	CrCbGaD
Atomoxetine—Maprotiline—HTR7—alcohol dependence	0.000139	0.037	CrCbGaD
Atomoxetine—Paraesthesia—Naltrexone—alcohol dependence	0.000139	0.00115	CcSEcCtD
Atomoxetine—Somnolence—Naltrexone—alcohol dependence	0.000137	0.00114	CcSEcCtD
Atomoxetine—Hypoaesthesia—Citalopram—alcohol dependence	0.000137	0.00113	CcSEcCtD
Atomoxetine—Hallucination—Citalopram—alcohol dependence	0.000137	0.00113	CcSEcCtD
Atomoxetine—Urinary tract disorder—Citalopram—alcohol dependence	0.000136	0.00112	CcSEcCtD
Atomoxetine—CYP3A4—blood—alcohol dependence	0.000136	0.00315	CbGeAlD
Atomoxetine—Urethral disorder—Citalopram—alcohol dependence	0.000135	0.00112	CcSEcCtD
Atomoxetine—Feeling abnormal—Acamprosate—alcohol dependence	0.000135	0.00111	CcSEcCtD
Atomoxetine—Decreased appetite—Naltrexone—alcohol dependence	0.000134	0.00111	CcSEcCtD
Atomoxetine—CYP2D6—blood—alcohol dependence	0.000134	0.0031	CbGeAlD
Atomoxetine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000134	0.0011	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000133	0.0011	CcSEcCtD
Atomoxetine—Fatigue—Naltrexone—alcohol dependence	0.000133	0.0011	CcSEcCtD
Atomoxetine—Pain—Naltrexone—alcohol dependence	0.000132	0.00109	CcSEcCtD
Atomoxetine—Constipation—Naltrexone—alcohol dependence	0.000132	0.00109	CcSEcCtD
Atomoxetine—Benzatropine—SLC6A3—alcohol dependence	0.000131	0.035	CrCbGaD
Atomoxetine—Pseudoephedrine—MAOA—alcohol dependence	0.000131	0.0349	CrCbGaD
Atomoxetine—Urticaria—Acamprosate—alcohol dependence	0.00013	0.00107	CcSEcCtD
Atomoxetine—Abdominal pain—Acamprosate—alcohol dependence	0.000129	0.00107	CcSEcCtD
Atomoxetine—Body temperature increased—Acamprosate—alcohol dependence	0.000129	0.00107	CcSEcCtD
Atomoxetine—Cardiac disorder—Citalopram—alcohol dependence	0.000128	0.00106	CcSEcCtD
Atomoxetine—Flushing—Citalopram—alcohol dependence	0.000128	0.00106	CcSEcCtD
Atomoxetine—HTR2A—endocrine gland—alcohol dependence	0.000127	0.00296	CbGeAlD
Atomoxetine—Feeling abnormal—Naltrexone—alcohol dependence	0.000127	0.00105	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000126	0.00104	CcSEcCtD
Atomoxetine—Angiopathy—Citalopram—alcohol dependence	0.000125	0.00103	CcSEcCtD
Atomoxetine—Mediastinal disorder—Citalopram—alcohol dependence	0.000124	0.00103	CcSEcCtD
Atomoxetine—Chills—Citalopram—alcohol dependence	0.000124	0.00102	CcSEcCtD
Atomoxetine—Urticaria—Naltrexone—alcohol dependence	0.000123	0.00101	CcSEcCtD
Atomoxetine—Abdominal pain—Naltrexone—alcohol dependence	0.000122	0.00101	CcSEcCtD
Atomoxetine—Body temperature increased—Naltrexone—alcohol dependence	0.000122	0.00101	CcSEcCtD
Atomoxetine—Maprotiline—SLC6A3—alcohol dependence	0.000122	0.0324	CrCbGaD
Atomoxetine—HTR2A—testis—alcohol dependence	0.000121	0.00282	CbGeAlD
Atomoxetine—Mental disorder—Citalopram—alcohol dependence	0.000121	0.000998	CcSEcCtD
Atomoxetine—Malnutrition—Citalopram—alcohol dependence	0.00012	0.000991	CcSEcCtD
Atomoxetine—Duloxetine—SLC6A4—alcohol dependence	0.000119	0.0318	CrCbGaD
Atomoxetine—HTR2A—nervous system—alcohol dependence	0.000119	0.00277	CbGeAlD
Atomoxetine—Flatulence—Citalopram—alcohol dependence	0.000118	0.000977	CcSEcCtD
Atomoxetine—CYP3A4—endocrine gland—alcohol dependence	0.000118	0.00274	CbGeAlD
Atomoxetine—Tension—Citalopram—alcohol dependence	0.000118	0.000973	CcSEcCtD
Atomoxetine—Dysgeusia—Citalopram—alcohol dependence	0.000117	0.000971	CcSEcCtD
Atomoxetine—Asthenia—Acamprosate—alcohol dependence	0.000117	0.000968	CcSEcCtD
Atomoxetine—Nervousness—Citalopram—alcohol dependence	0.000116	0.000963	CcSEcCtD
Atomoxetine—CYP2D6—endocrine gland—alcohol dependence	0.000116	0.00269	CbGeAlD
Atomoxetine—Back pain—Citalopram—alcohol dependence	0.000116	0.000959	CcSEcCtD
Atomoxetine—Methadone—OPRD1—alcohol dependence	0.000116	0.0308	CrCbGaD
Atomoxetine—Pruritus—Acamprosate—alcohol dependence	0.000116	0.000955	CcSEcCtD
Atomoxetine—Muscle spasms—Citalopram—alcohol dependence	0.000115	0.000953	CcSEcCtD
Atomoxetine—HTR2A—liver—alcohol dependence	0.000115	0.00266	CbGeAlD
Atomoxetine—HTR2A—central nervous system—alcohol dependence	0.000115	0.00266	CbGeAlD
Atomoxetine—Vision blurred—Citalopram—alcohol dependence	0.000113	0.000934	CcSEcCtD
Atomoxetine—Pseudoephedrine—SLC6A3—alcohol dependence	0.000113	0.0301	CrCbGaD
Atomoxetine—Tremor—Citalopram—alcohol dependence	0.000112	0.000929	CcSEcCtD
Atomoxetine—HTR2A—cerebellum—alcohol dependence	0.000112	0.0026	CbGeAlD
Atomoxetine—Diarrhoea—Acamprosate—alcohol dependence	0.000112	0.000924	CcSEcCtD
Atomoxetine—Asthenia—Naltrexone—alcohol dependence	0.000111	0.000916	CcSEcCtD
Atomoxetine—CYP2D6—testis—alcohol dependence	0.000111	0.00257	CbGeAlD
Atomoxetine—CYP3A4—nervous system—alcohol dependence	0.00011	0.00256	CbGeAlD
Atomoxetine—Agitation—Citalopram—alcohol dependence	0.00011	0.000911	CcSEcCtD
Atomoxetine—Pruritus—Naltrexone—alcohol dependence	0.000109	0.000904	CcSEcCtD
Atomoxetine—CYP2D6—nervous system—alcohol dependence	0.000109	0.00252	CbGeAlD
Atomoxetine—Dizziness—Acamprosate—alcohol dependence	0.000108	0.000893	CcSEcCtD
Atomoxetine—Vertigo—Citalopram—alcohol dependence	0.000108	0.000891	CcSEcCtD
Atomoxetine—Syncope—Citalopram—alcohol dependence	0.000108	0.000889	CcSEcCtD
Atomoxetine—CYP3A4—liver—alcohol dependence	0.000106	0.00247	CbGeAlD
Atomoxetine—CYP3A4—central nervous system—alcohol dependence	0.000106	0.00247	CbGeAlD
Atomoxetine—Palpitations—Citalopram—alcohol dependence	0.000106	0.000876	CcSEcCtD
Atomoxetine—Diarrhoea—Naltrexone—alcohol dependence	0.000106	0.000874	CcSEcCtD
Atomoxetine—Loss of consciousness—Citalopram—alcohol dependence	0.000105	0.000871	CcSEcCtD
Atomoxetine—Cough—Citalopram—alcohol dependence	0.000105	0.000865	CcSEcCtD
Atomoxetine—CYP2D6—liver—alcohol dependence	0.000105	0.00243	CbGeAlD
Atomoxetine—CYP2D6—central nervous system—alcohol dependence	0.000105	0.00243	CbGeAlD
Atomoxetine—Convulsion—Citalopram—alcohol dependence	0.000104	0.000859	CcSEcCtD
Atomoxetine—Vomiting—Acamprosate—alcohol dependence	0.000104	0.000858	CcSEcCtD
Atomoxetine—Rash—Acamprosate—alcohol dependence	0.000103	0.000851	CcSEcCtD
Atomoxetine—Dermatitis—Acamprosate—alcohol dependence	0.000103	0.00085	CcSEcCtD
Atomoxetine—Headache—Acamprosate—alcohol dependence	0.000102	0.000846	CcSEcCtD
Atomoxetine—CYP2D6—cerebellum—alcohol dependence	0.000102	0.00237	CbGeAlD
Atomoxetine—Dizziness—Naltrexone—alcohol dependence	0.000102	0.000845	CcSEcCtD
Atomoxetine—Myalgia—Citalopram—alcohol dependence	0.000102	0.000844	CcSEcCtD
Atomoxetine—Arthralgia—Citalopram—alcohol dependence	0.000102	0.000844	CcSEcCtD
Atomoxetine—Chest pain—Citalopram—alcohol dependence	0.000102	0.000844	CcSEcCtD
Atomoxetine—Anxiety—Citalopram—alcohol dependence	0.000102	0.000841	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000101	0.000838	CcSEcCtD
Atomoxetine—Dry mouth—Citalopram—alcohol dependence	9.98e-05	0.000826	CcSEcCtD
Atomoxetine—Vomiting—Naltrexone—alcohol dependence	9.82e-05	0.000812	CcSEcCtD
Atomoxetine—Rash—Naltrexone—alcohol dependence	9.74e-05	0.000805	CcSEcCtD
Atomoxetine—Dermatitis—Naltrexone—alcohol dependence	9.73e-05	0.000804	CcSEcCtD
Atomoxetine—Fluoxetine—SLC6A4—alcohol dependence	9.72e-05	0.0259	CrCbGaD
Atomoxetine—Infection—Citalopram—alcohol dependence	9.72e-05	0.000804	CcSEcCtD
Atomoxetine—Modafinil—SLC6A3—alcohol dependence	9.71e-05	0.0259	CrCbGaD
Atomoxetine—Nausea—Acamprosate—alcohol dependence	9.7e-05	0.000802	CcSEcCtD
Atomoxetine—Headache—Naltrexone—alcohol dependence	9.68e-05	0.0008	CcSEcCtD
Atomoxetine—Shock—Citalopram—alcohol dependence	9.63e-05	0.000796	CcSEcCtD
Atomoxetine—Nervous system disorder—Citalopram—alcohol dependence	9.6e-05	0.000794	CcSEcCtD
Atomoxetine—Tachycardia—Citalopram—alcohol dependence	9.55e-05	0.00079	CcSEcCtD
Atomoxetine—Skin disorder—Citalopram—alcohol dependence	9.51e-05	0.000786	CcSEcCtD
Atomoxetine—Hyperhidrosis—Citalopram—alcohol dependence	9.46e-05	0.000782	CcSEcCtD
Atomoxetine—Anorexia—Citalopram—alcohol dependence	9.33e-05	0.000771	CcSEcCtD
Atomoxetine—Nausea—Naltrexone—alcohol dependence	9.18e-05	0.000759	CcSEcCtD
Atomoxetine—Duloxetine—HTR2A—alcohol dependence	9.17e-05	0.0244	CrCbGaD
Atomoxetine—HTR2A—brain—alcohol dependence	9.11e-05	0.00211	CbGeAlD
Atomoxetine—Maprotiline—DRD2—alcohol dependence	9.04e-05	0.0241	CrCbGaD
Atomoxetine—Musculoskeletal discomfort—Citalopram—alcohol dependence	8.92e-05	0.000737	CcSEcCtD
Atomoxetine—Insomnia—Citalopram—alcohol dependence	8.85e-05	0.000732	CcSEcCtD
Atomoxetine—Methadone—OPRM1—alcohol dependence	8.84e-05	0.0236	CrCbGaD
Atomoxetine—Paraesthesia—Citalopram—alcohol dependence	8.79e-05	0.000727	CcSEcCtD
Atomoxetine—Propranolol—HTR1B—alcohol dependence	8.79e-05	0.0234	CrCbGaD
Atomoxetine—Somnolence—Citalopram—alcohol dependence	8.7e-05	0.000719	CcSEcCtD
Atomoxetine—Dyspepsia—Citalopram—alcohol dependence	8.62e-05	0.000712	CcSEcCtD
Atomoxetine—Decreased appetite—Citalopram—alcohol dependence	8.51e-05	0.000703	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Citalopram—alcohol dependence	8.45e-05	0.000699	CcSEcCtD
Atomoxetine—Pseudoephedrine—SLC6A4—alcohol dependence	8.45e-05	0.0225	CrCbGaD
Atomoxetine—Fatigue—Citalopram—alcohol dependence	8.44e-05	0.000698	CcSEcCtD
Atomoxetine—Benzphetamine—SLC6A3—alcohol dependence	8.42e-05	0.0224	CrCbGaD
Atomoxetine—Nortriptyline—CHRM2—alcohol dependence	8.38e-05	0.0223	CrCbGaD
Atomoxetine—Constipation—Citalopram—alcohol dependence	8.37e-05	0.000692	CcSEcCtD
Atomoxetine—Pain—Citalopram—alcohol dependence	8.37e-05	0.000692	CcSEcCtD
Atomoxetine—CYP2D6—brain—alcohol dependence	8.3e-05	0.00193	CbGeAlD
Atomoxetine—Feeling abnormal—Citalopram—alcohol dependence	8.07e-05	0.000667	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Citalopram—alcohol dependence	8e-05	0.000662	CcSEcCtD
Atomoxetine—Urticaria—Citalopram—alcohol dependence	7.78e-05	0.000643	CcSEcCtD
Atomoxetine—Diphenhydramine—CHRM2—alcohol dependence	7.75e-05	0.0206	CrCbGaD
Atomoxetine—Abdominal pain—Citalopram—alcohol dependence	7.74e-05	0.00064	CcSEcCtD
Atomoxetine—Body temperature increased—Citalopram—alcohol dependence	7.74e-05	0.00064	CcSEcCtD
Atomoxetine—Fluoxetine—HTR2A—alcohol dependence	7.47e-05	0.0199	CrCbGaD
Atomoxetine—Orphenadrine—CHRM2—alcohol dependence	7.33e-05	0.0195	CrCbGaD
Atomoxetine—Asthenia—Citalopram—alcohol dependence	7.02e-05	0.000581	CcSEcCtD
Atomoxetine—Maprotiline—HTR2A—alcohol dependence	6.98e-05	0.0186	CrCbGaD
Atomoxetine—Pruritus—Citalopram—alcohol dependence	6.92e-05	0.000572	CcSEcCtD
Atomoxetine—Desipramine—CHRM2—alcohol dependence	6.9e-05	0.0184	CrCbGaD
Atomoxetine—Diarrhoea—Citalopram—alcohol dependence	6.7e-05	0.000554	CcSEcCtD
Atomoxetine—Dizziness—Citalopram—alcohol dependence	6.47e-05	0.000535	CcSEcCtD
Atomoxetine—Vomiting—Citalopram—alcohol dependence	6.22e-05	0.000514	CcSEcCtD
Atomoxetine—Rash—Citalopram—alcohol dependence	6.17e-05	0.00051	CcSEcCtD
Atomoxetine—Dermatitis—Citalopram—alcohol dependence	6.17e-05	0.00051	CcSEcCtD
Atomoxetine—Headache—Citalopram—alcohol dependence	6.13e-05	0.000507	CcSEcCtD
Atomoxetine—Desipramine—SLC6A3—alcohol dependence	6.01e-05	0.016	CrCbGaD
Atomoxetine—Nausea—Citalopram—alcohol dependence	5.81e-05	0.000481	CcSEcCtD
Atomoxetine—Nortriptyline—SLC6A4—alcohol dependence	5.46e-05	0.0145	CrCbGaD
Atomoxetine—Nortriptyline—DRD2—alcohol dependence	5.43e-05	0.0145	CrCbGaD
Atomoxetine—Nortriptyline—CYP2E1—alcohol dependence	5.22e-05	0.0139	CrCbGaD
Atomoxetine—Orphenadrine—CYP2E1—alcohol dependence	4.57e-05	0.0122	CrCbGaD
Atomoxetine—Desipramine—SLC6A4—alcohol dependence	4.49e-05	0.012	CrCbGaD
Atomoxetine—Desipramine—DRD2—alcohol dependence	4.47e-05	0.0119	CrCbGaD
Atomoxetine—Desipramine—CYP2E1—alcohol dependence	4.3e-05	0.0115	CrCbGaD
Atomoxetine—Nortriptyline—HTR2A—alcohol dependence	4.19e-05	0.0112	CrCbGaD
Atomoxetine—Desipramine—HTR2A—alcohol dependence	3.45e-05	0.0092	CrCbGaD
Atomoxetine—HTR2C—Signaling Pathways—OPRK1—alcohol dependence	2.08e-05	0.000268	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—AVP—alcohol dependence	2.07e-05	0.000267	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—OPRD1—alcohol dependence	2.05e-05	0.000265	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—DRD4—alcohol dependence	2.05e-05	0.000265	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CNR1—alcohol dependence	2.01e-05	0.00026	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CRHR1—alcohol dependence	2.01e-05	0.00026	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—OPRM1—alcohol dependence	2e-05	0.000259	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR2A—alcohol dependence	2e-05	0.000259	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CNR1—alcohol dependence	2e-05	0.000258	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CHRM2—alcohol dependence	1.98e-05	0.000256	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—PDYN—alcohol dependence	1.97e-05	0.000254	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—DRD2—alcohol dependence	1.96e-05	0.000254	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR7—alcohol dependence	1.96e-05	0.000254	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CNR1—alcohol dependence	1.96e-05	0.000253	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR7—alcohol dependence	1.95e-05	0.000252	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—DRD2—alcohol dependence	1.95e-05	0.000252	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—POMC—alcohol dependence	1.94e-05	0.000251	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—POMC—alcohol dependence	1.93e-05	0.000249	CbGpPWpGaD
Atomoxetine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	1.92e-05	0.000249	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—DRD4—alcohol dependence	1.91e-05	0.000248	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR7—alcohol dependence	1.91e-05	0.000247	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—DRD2—alcohol dependence	1.91e-05	0.000247	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	1.91e-05	0.000247	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—DRD4—alcohol dependence	1.9e-05	0.000246	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—OPRD1—alcohol dependence	1.89e-05	0.000245	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CHRM2—alcohol dependence	1.89e-05	0.000245	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—EP300—alcohol dependence	1.89e-05	0.000244	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—POMC—alcohol dependence	1.89e-05	0.000244	CbGpPWpGaD
Atomoxetine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	1.88e-05	0.000243	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.88e-05	0.000243	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—OPRD1—alcohol dependence	1.88e-05	0.000243	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—AVP—alcohol dependence	1.87e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—DRD4—alcohol dependence	1.86e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—NPY—alcohol dependence	1.84e-05	0.000238	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—OPRD1—alcohol dependence	1.84e-05	0.000238	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADH6—alcohol dependence	1.83e-05	0.000237	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—AVP—alcohol dependence	1.83e-05	0.000237	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CNR1—alcohol dependence	1.83e-05	0.000236	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CRHR1—alcohol dependence	1.83e-05	0.000236	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—OPRM1—alcohol dependence	1.82e-05	0.000235	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PDYN—alcohol dependence	1.82e-05	0.000235	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CNR1—alcohol dependence	1.81e-05	0.000235	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—OPRK1—alcohol dependence	1.8e-05	0.000233	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PDYN—alcohol dependence	1.8e-05	0.000233	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR2A—alcohol dependence	1.79e-05	0.000232	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—DRD2—alcohol dependence	1.78e-05	0.000231	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR7—alcohol dependence	1.78e-05	0.000231	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CNR1—alcohol dependence	1.78e-05	0.00023	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR1B—alcohol dependence	1.78e-05	0.00023	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CRH—alcohol dependence	1.78e-05	0.00023	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—DRD2—alcohol dependence	1.77e-05	0.000229	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR7—alcohol dependence	1.77e-05	0.000229	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PDYN—alcohol dependence	1.76e-05	0.000228	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	1.75e-05	0.000226	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—OPRM1—alcohol dependence	1.74e-05	0.000225	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR7—alcohol dependence	1.73e-05	0.000224	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—DRD2—alcohol dependence	1.73e-05	0.000224	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CHRM2—alcohol dependence	1.72e-05	0.000222	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—POMC—alcohol dependence	1.7e-05	0.00022	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—WASF2—alcohol dependence	1.69e-05	0.000218	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CRHR1—alcohol dependence	1.69e-05	0.000218	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADH6—alcohol dependence	1.69e-05	0.000218	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—WASF2—alcohol dependence	1.68e-05	0.000217	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CRHR1—alcohol dependence	1.68e-05	0.000217	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—NPY—alcohol dependence	1.67e-05	0.000216	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—AVP—alcohol dependence	1.65e-05	0.000214	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—AVP—alcohol dependence	1.64e-05	0.000212	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CRHR1—alcohol dependence	1.64e-05	0.000212	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—WASF2—alcohol dependence	1.64e-05	0.000212	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.63e-05	0.000211	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—WASF1—alcohol dependence	1.62e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR1B—alcohol dependence	1.61e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CRH—alcohol dependence	1.61e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—AVP—alcohol dependence	1.61e-05	0.000208	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—WASF1—alcohol dependence	1.61e-05	0.000208	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—NPY—alcohol dependence	1.6e-05	0.000207	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—POMC—alcohol dependence	1.6e-05	0.000207	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CHRM2—alcohol dependence	1.59e-05	0.000205	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—OPRM1—alcohol dependence	1.58e-05	0.000204	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CHRM2—alcohol dependence	1.58e-05	0.000204	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—WASF1—alcohol dependence	1.57e-05	0.000203	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	1.57e-05	0.000203	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—POMC—alcohol dependence	1.56e-05	0.000202	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—DRD4—alcohol dependence	1.55e-05	0.000201	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR1B—alcohol dependence	1.54e-05	0.000199	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CRH—alcohol dependence	1.54e-05	0.000199	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CHRM2—alcohol dependence	1.54e-05	0.000199	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADH1A—alcohol dependence	1.52e-05	0.000196	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—AVP—alcohol dependence	1.5e-05	0.000194	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—AVP—alcohol dependence	1.49e-05	0.000193	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CNR1—alcohol dependence	1.48e-05	0.000192	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—AVP—alcohol dependence	1.46e-05	0.000189	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—OPRM1—alcohol dependence	1.46e-05	0.000188	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—NPY—alcohol dependence	1.45e-05	0.000188	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR7—alcohol dependence	1.45e-05	0.000187	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—DRD2—alcohol dependence	1.45e-05	0.000187	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—OPRM1—alcohol dependence	1.45e-05	0.000187	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—POMC—alcohol dependence	1.43e-05	0.000185	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—OPRM1—alcohol dependence	1.42e-05	0.000183	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—DRD4—alcohol dependence	1.41e-05	0.000182	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CRH—alcohol dependence	1.4e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR1B—alcohol dependence	1.4e-05	0.000181	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADH1A—alcohol dependence	1.4e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—OPRD1—alcohol dependence	1.39e-05	0.00018	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR2A—alcohol dependence	1.38e-05	0.000178	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR2A—alcohol dependence	1.37e-05	0.000176	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—DRD4—alcohol dependence	1.35e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CNR1—alcohol dependence	1.35e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NPY—alcohol dependence	1.34e-05	0.000173	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PDYN—alcohol dependence	1.34e-05	0.000173	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR2A—alcohol dependence	1.34e-05	0.000173	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NPY—alcohol dependence	1.33e-05	0.000172	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—DRD2—alcohol dependence	1.31e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR7—alcohol dependence	1.31e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NPY—alcohol dependence	1.3e-05	0.000168	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR1B—alcohol dependence	1.29e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CRH—alcohol dependence	1.29e-05	0.000167	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADH4—alcohol dependence	1.29e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CNR1—alcohol dependence	1.29e-05	0.000166	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR1B—alcohol dependence	1.28e-05	0.000166	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CRH—alcohol dependence	1.28e-05	0.000166	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CRH—alcohol dependence	1.26e-05	0.000163	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—DRD2—alcohol dependence	1.26e-05	0.000162	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR7—alcohol dependence	1.26e-05	0.000162	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR2A—alcohol dependence	1.25e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CRHR1—alcohol dependence	1.24e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—WASF2—alcohol dependence	1.24e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—POMC—alcohol dependence	1.24e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR2A—alcohol dependence	1.24e-05	0.00016	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—DRD4—alcohol dependence	1.22e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—AVP—alcohol dependence	1.22e-05	0.000157	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR2A—alcohol dependence	1.21e-05	0.000157	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—OPRD1—alcohol dependence	1.21e-05	0.000157	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—WASF1—alcohol dependence	1.19e-05	0.000154	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADH4—alcohol dependence	1.19e-05	0.000154	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CNR1—alcohol dependence	1.17e-05	0.000151	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CHRM2—alcohol dependence	1.17e-05	0.000151	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PDYN—alcohol dependence	1.16e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—DRD2—alcohol dependence	1.14e-05	0.000147	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR7—alcohol dependence	1.14e-05	0.000147	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—DRD4—alcohol dependence	1.13e-05	0.000146	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—DRD4—alcohol dependence	1.12e-05	0.000145	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.12e-05	0.000145	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—AVP—alcohol dependence	1.11e-05	0.000143	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADH6—alcohol dependence	1.1e-05	0.000143	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—DRD4—alcohol dependence	1.1e-05	0.000142	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—POMC—alcohol dependence	1.1e-05	0.000142	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADH7—alcohol dependence	1.1e-05	0.000142	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—POMC—alcohol dependence	1.09e-05	0.000141	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CNR1—alcohol dependence	1.08e-05	0.00014	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—WASF2—alcohol dependence	1.08e-05	0.00014	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CRHR1—alcohol dependence	1.08e-05	0.00014	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—OPRM1—alcohol dependence	1.07e-05	0.000139	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CNR1—alcohol dependence	1.07e-05	0.000139	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—POMC—alcohol dependence	1.07e-05	0.000138	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—EP300—alcohol dependence	1.06e-05	0.000137	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—AVP—alcohol dependence	1.06e-05	0.000137	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR7—alcohol dependence	1.05e-05	0.000136	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—DRD2—alcohol dependence	1.05e-05	0.000136	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GGT2—alcohol dependence	1.05e-05	0.000136	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CNR1—alcohol dependence	1.05e-05	0.000136	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—DRD2—alcohol dependence	1.05e-05	0.000135	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR7—alcohol dependence	1.05e-05	0.000135	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—WASF1—alcohol dependence	1.04e-05	0.000134	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—DRD2—alcohol dependence	1.02e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR7—alcohol dependence	1.02e-05	0.000132	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.02e-05	0.000132	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CHRM2—alcohol dependence	1.02e-05	0.000131	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR2A—alcohol dependence	1.01e-05	0.000131	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADH7—alcohol dependence	1.01e-05	0.000131	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—POMC—alcohol dependence	9.98e-06	0.000129	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—POMC—alcohol dependence	9.9e-06	0.000128	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NPY—alcohol dependence	9.88e-06	0.000128	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—POMC—alcohol dependence	9.69e-06	0.000125	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GGT2—alcohol dependence	9.68e-06	0.000125	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADH1B—alcohol dependence	9.63e-06	0.000124	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—AVP—alcohol dependence	9.6e-06	0.000124	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR1B—alcohol dependence	9.53e-06	0.000123	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CRH—alcohol dependence	9.53e-06	0.000123	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—OPRM1—alcohol dependence	9.32e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR2A—alcohol dependence	9.2e-06	0.000119	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADH1A—alcohol dependence	9.13e-06	0.000118	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—AVP—alcohol dependence	8.87e-06	0.000115	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADH1B—alcohol dependence	8.86e-06	0.000114	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—AVP—alcohol dependence	8.8e-06	0.000114	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—AVP—alcohol dependence	8.62e-06	0.000111	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NPY—alcohol dependence	8.58e-06	0.000111	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—DRD4—alcohol dependence	8.33e-06	0.000108	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CRH—alcohol dependence	8.27e-06	0.000107	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR1B—alcohol dependence	8.27e-06	0.000107	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—POMC—alcohol dependence	8.09e-06	0.000105	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MAOB—alcohol dependence	7.98e-06	0.000103	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CNR1—alcohol dependence	7.95e-06	0.000103	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADH4—alcohol dependence	7.77e-06	0.0001	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—DRD2—alcohol dependence	7.76e-06	0.0001	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR7—alcohol dependence	7.76e-06	0.0001	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2A—alcohol dependence	7.38e-06	9.54e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—POMC—alcohol dependence	7.35e-06	9.5e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MAOB—alcohol dependence	7.34e-06	9.49e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2A—alcohol dependence	7.32e-06	9.47e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—DRD4—alcohol dependence	7.23e-06	9.35e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2A—alcohol dependence	7.17e-06	9.27e-05	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—POMC—alcohol dependence	7.03e-06	9.08e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CNR1—alcohol dependence	6.91e-06	8.93e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALDH2—alcohol dependence	6.78e-06	8.77e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—DRD2—alcohol dependence	6.74e-06	8.71e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR7—alcohol dependence	6.74e-06	8.71e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADH7—alcohol dependence	6.6e-06	8.54e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—AVP—alcohol dependence	6.53e-06	8.44e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.52e-06	8.43e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—POMC—alcohol dependence	6.38e-06	8.25e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GGT2—alcohol dependence	6.33e-06	8.18e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALDH2—alcohol dependence	6.24e-06	8.07e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—POMC—alcohol dependence	5.89e-06	7.62e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—POMC—alcohol dependence	5.85e-06	7.56e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADH1B—alcohol dependence	5.79e-06	7.49e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT2—alcohol dependence	5.77e-06	7.46e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—POMC—alcohol dependence	5.73e-06	7.4e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AVP—alcohol dependence	5.67e-06	7.33e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR2A—alcohol dependence	5.43e-06	7.03e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CYP2E1—alcohol dependence	5.42e-06	7.01e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT2—alcohol dependence	5.31e-06	6.86e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	4.99e-06	6.45e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GGT1—alcohol dependence	4.98e-06	6.44e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT1—alcohol dependence	4.98e-06	6.44e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MAOB—alcohol dependence	4.8e-06	6.2e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT1—alcohol dependence	4.58e-06	5.92e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GGT1—alcohol dependence	4.58e-06	5.92e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MAOA—alcohol dependence	4.46e-06	5.77e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—POMC—alcohol dependence	4.34e-06	5.61e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.33e-06	5.59e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MAOA—alcohol dependence	4.1e-06	5.31e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALDH2—alcohol dependence	4.08e-06	5.27e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—EP300—alcohol dependence	3.91e-06	5.05e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—EP300—alcohol dependence	3.88e-06	5.02e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—EP300—alcohol dependence	3.8e-06	4.91e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—POMC—alcohol dependence	3.77e-06	4.87e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT2—alcohol dependence	3.47e-06	4.48e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.26e-06	4.22e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT1—alcohol dependence	2.99e-06	3.87e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GGT1—alcohol dependence	2.99e-06	3.87e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—POMC—alcohol dependence	2.9e-06	3.76e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—EP300—alcohol dependence	2.88e-06	3.72e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MAOA—alcohol dependence	2.68e-06	3.47e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—POMC—alcohol dependence	2.67e-06	3.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—EP300—alcohol dependence	2.5e-06	3.23e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—EP300—alcohol dependence	1.93e-06	2.49e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—EP300—alcohol dependence	1.77e-06	2.29e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—POMC—alcohol dependence	1.75e-06	2.26e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—EP300—alcohol dependence	1.16e-06	1.5e-05	CbGpPWpGaD
